$AVAH
Aveanna Healthcare Holdings, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024122748 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $509.0M
YoY Change 7.86%
Cost Of Revenue $349.3M
YoY Change 10.3%
Gross Profit $159.7M
YoY Change 2.86%
Gross Profit Margin 31.37%
Selling, General & Admin $88.18M
YoY Change -3.37%
% of Gross Profit 55.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.587M
YoY Change -25.9%
% of Gross Profit 1.62%
Operating Expenses $88.18M
YoY Change -3.37%
Operating Profit $34.02M
YoY Change -9.25%
Interest Expense $39.25M
YoY Change 3.32%
% of Operating Profit 115.35%
Other Income/Expense, Net -$22.21M
YoY Change -188.25%
Pretax Income -$27.33M
YoY Change -210.26%
Income Tax $15.50M
% Of Pretax Income
Net Earnings -$42.84M
YoY Change -267.36%
Net Earnings / Revenue -8.42%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$0.22
COMMON SHARES
Basic Shares Outstanding 193.2M 193.2M
Diluted Shares Outstanding 193.4M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $78.46M
YoY Change 180.1%
Cash & Equivalents $78.46M
Short-Term Investments
Other Short-Term Assets $12.43M
YoY Change -4.46%
Inventory
Prepaid Expenses $12.20M
Receivables $265.4M
Other Receivables $0.00
Total Short-Term Assets $381.4M
YoY Change 26.58%
LONG-TERM ASSETS
Property, Plant & Equipment $18.04M
YoY Change -9.08%
Goodwill $1.055B
YoY Change -9.07%
Intangibles $89.75M
YoY Change -7.26%
Long-Term Investments
YoY Change
Other Assets $32.20M
YoY Change -61.89%
Total Long-Term Assets $1.263B
YoY Change -12.31%
TOTAL ASSETS
Total Short-Term Assets $381.4M
Total Long-Term Assets $1.263B
Total Assets $1.644B
YoY Change -5.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.93M
YoY Change 9.08%
Accrued Expenses $100.3M
YoY Change 34.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $9.200M
YoY Change 0.0%
Total Short-Term Liabilities $406.0M
YoY Change 14.18%
LONG-TERM LIABILITIES
Long-Term Debt $1.275B
YoY Change -0.29%
Other Long-Term Liabilities $5.849M
YoY Change 2570.78%
Total Long-Term Liabilities $1.281B
YoY Change 0.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $406.0M
Total Long-Term Liabilities $1.281B
Total Liabilities $1.799B
YoY Change 3.04%
SHAREHOLDERS EQUITY
Retained Earnings -$1.411B
YoY Change 13.53%
Common Stock $1.255B
YoY Change 1.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$156.4M
YoY Change
Total Liabilities & Shareholders Equity $1.644B
YoY Change -5.58%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$42.84M
YoY Change -267.36%
Depreciation, Depletion And Amortization $2.587M
YoY Change -25.9%
Cash From Operating Activities $29.39M
YoY Change -379.46%
INVESTING ACTIVITIES
Capital Expenditures $2.213M
YoY Change 70.36%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.213M
YoY Change 70.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.620M
YoY Change -32.91%
NET CHANGE
Cash From Operating Activities 29.39M
Cash From Investing Activities -2.213M
Cash From Financing Activities 3.620M
Net Change In Cash 30.80M
YoY Change -579.69%
FREE CASH FLOW
Cash From Operating Activities $29.39M
Capital Expenditures $2.213M
Free Cash Flow $27.18M
YoY Change -330.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001832332
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1411343000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1371234000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-156442000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-129570000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1644166000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1612985000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509023000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
478010000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1504634000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1416368000
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
349324000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
330746000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1040814000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
969384000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88184000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91004000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
264070000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
273967000
CY2024Q3 avah Corporate Expenses
CorporateExpenses
31894000
CY2023Q3 avah Corporate Expenses
CorporateExpenses
27446000
avah Corporate Expenses
CorporateExpenses
91981000
avah Corporate Expenses
CorporateExpenses
84735000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2587000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2962000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8332000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
428000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
466000
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2860000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3360000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6593000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34024000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76352000
us-gaap Operating Income Loss
OperatingIncomeLoss
94016000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21221000
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40362
dei Entity Registrant Name
EntityRegistrantName
Aveanna Healthcare Holdings Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4717209
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Interstate North Parkway SE
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
441-1580
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
AVAH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
193225177
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78462000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43942000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
265449000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
236558000
CY2024Q3 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
12828000
CY2023Q4 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
9250000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12202000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15684000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
12425000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9452000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
381366000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
314886000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18038000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20548000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42548000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49499000
CY2024Q3 us-gaap Goodwill
Goodwill
1054552000
CY2023Q4 us-gaap Goodwill
Goodwill
1054552000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
89746000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
94010000
CY2024Q3 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
25712000
CY2023Q4 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
21315000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32204000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58175000
CY2024Q3 us-gaap Assets
Assets
1644166000
CY2023Q4 us-gaap Assets
Assets
1612985000
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
41925000
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
30130000
CY2024Q3 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
84983000
CY2023Q4 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
67160000
CY2024Q3 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
12828000
CY2023Q4 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
9250000
CY2024Q3 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
20567000
CY2023Q4 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
20918000
CY2024Q3 avah Securitization Obligations
SecuritizationObligations
170000000
CY2023Q4 avah Securitization Obligations
SecuritizationObligations
155000000
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
9200000
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
9200000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15290000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14881000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
51243000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48219000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
406036000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
354758000
CY2024Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1275084000
CY2023Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1276341000
CY2024Q3 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
25712000
CY2023Q4 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
21315000
CY2024Q3 avah Long Term Insurance Reserves
LongTermInsuranceReserves
47583000
CY2023Q4 avah Long Term Insurance Reserves
LongTermInsuranceReserves
40290000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33497000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
39818000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5386000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4859000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5849000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3039000
CY2024Q3 us-gaap Liabilities
Liabilities
1799147000
CY2023Q4 us-gaap Liabilities
Liabilities
1740420000
CY2024Q3 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
1461000
CY2023Q4 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
193225177
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193225177
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
190733153
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190733153
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1931000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1907000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1252970000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1239757000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1411343000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1371234000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-156442000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-129570000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1644166000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1612985000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509023000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
478010000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1504634000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1416368000
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
349324000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
330746000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1040814000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91004000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
273967000
CY2024Q3 avah Corporate Expenses
CorporateExpenses
31894000
CY2023Q3 avah Corporate Expenses
CorporateExpenses
27446000
avah Corporate Expenses
CorporateExpenses
91981000
avah Corporate Expenses
CorporateExpenses
84735000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2587000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2962000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8332000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
428000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
466000
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2860000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3360000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5271000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6593000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34024000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76352000
us-gaap Operating Income Loss
OperatingIncomeLoss
94016000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21221000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
us-gaap Investment Income Interest
InvestmentIncomeInterest
297000
us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
CY2024Q3 us-gaap Interest Expense
InterestExpense
39245000
CY2023Q3 us-gaap Interest Expense
InterestExpense
39599000
us-gaap Interest Expense
InterestExpense
118505000
us-gaap Interest Expense
InterestExpense
113542000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22211000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14143000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2329000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27124000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27332000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101758000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15511000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
631000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18246000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1387000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-42843000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
us-gaap Net Income Loss
NetIncomeLoss
-40109000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
193361000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193361000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189139000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189139000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
192734000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189632000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189632000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
us-gaap Investment Income Interest
InvestmentIncomeInterest
297000
us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
CY2024Q3 us-gaap Interest Expense
InterestExpense
39245000
CY2023Q3 us-gaap Interest Expense
InterestExpense
39599000
us-gaap Interest Expense
InterestExpense
118505000
us-gaap Interest Expense
InterestExpense
113542000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22211000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14143000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2329000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27124000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27332000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101758000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21863000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107401000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15511000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
631000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18246000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1387000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-42843000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
us-gaap Net Income Loss
NetIncomeLoss
-40109000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
193361000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193361000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189139000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189139000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192734000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
192734000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189632000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189632000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-118968000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1739000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3630000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-42843000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-156442000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6737000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3413000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-118968000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1739000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3630000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-42843000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-156442000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6737000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3413000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-129570000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
675000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3088000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9474000
us-gaap Net Income Loss
NetIncomeLoss
-40109000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-156442000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6310000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8440000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
us-gaap Profit Loss
ProfitLoss
-40109000
us-gaap Profit Loss
ProfitLoss
-108788000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8332000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15628000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12490000
us-gaap Share Based Compensation
ShareBasedCompensation
12483000
us-gaap Share Based Compensation
ShareBasedCompensation
10143000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
avah Gain Loss On Disposition Or Impairment Of Licenses Property And Equipment And Internal Use Software
GainLossOnDispositionOrImpairmentOfLicensesPropertyAndEquipmentAndInternalUseSoftware
-3212000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2584000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
527000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
575000
avah Non Cash Gain On Acquisition
NonCashGainOnAcquisition
5090000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28891000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14431000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5631000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5247000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
15678000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12657000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11919000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7861000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
17823000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
31752000
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
6942000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5335000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6944000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19231000
avah Purchase Of Certificates Of Need
PurchaseOfCertificatesOfNeed
2678000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9474000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
945000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8440000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8332000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3797000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3983000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15628000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12490000
us-gaap Share Based Compensation
ShareBasedCompensation
12483000
us-gaap Share Based Compensation
ShareBasedCompensation
10143000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
avah Gain Loss On Disposition Or Impairment Of Licenses Property And Equipment And Internal Use Software
GainLossOnDispositionOrImpairmentOfLicensesPropertyAndEquipmentAndInternalUseSoftware
-2086000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-26869000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2584000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
527000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
575000
avah Non Cash Gain On Acquisition
NonCashGainOnAcquisition
5090000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28891000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14431000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5631000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5247000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
15678000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12657000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11919000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7861000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
17823000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
31752000
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
6942000
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
229000
avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-14589000
avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-11991000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5335000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6944000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19231000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25677000
avah Purchase Of Certificates Of Need
PurchaseOfCertificatesOfNeed
2678000
avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
4790000
avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
4548000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4790000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7226000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3088000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
945000
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
25000000
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
45000000
avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
4790000
avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
4548000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4790000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7226000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3088000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
945000
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
25000000
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
45000000
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
10000000
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
30000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
20000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
20000000
avah Repayment Of Term Loans
RepaymentOfTermLoans
4600000
avah Repayment Of Term Loans
RepaymentOfTermLoans
6900000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4604000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7293000
avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
198000
avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
521000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
288000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1047000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-11681000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-10442000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20079000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10626000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29077000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43942000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19217000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
78462000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48294000
us-gaap Interest Paid Net
InterestPaidNet
114948000
us-gaap Interest Paid Net
InterestPaidNet
99291000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5646000
us-gaap Nature Of Operations
NatureOfOperations
<p id="notes_to_unaudited_consolidated_financia" style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. DESCRIPTION</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> OF BUSINESS</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has locations in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">33</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> states with concentrations in California, Texas and Pennsylvania, providing a broad range of pediatric and adult healthcare services, including nursing, hospice, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.</span></p>
CY2024Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
10000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
20000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
20000000
avah Repayment Of Term Loans
RepaymentOfTermLoans
6900000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7293000
avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
198000
avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
521000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-11681000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-10442000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20079000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10626000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34520000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29077000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43942000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19217000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
78462000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48294000
us-gaap Interest Paid Net
InterestPaidNet
114948000
us-gaap Interest Paid Net
InterestPaidNet
99291000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5646000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
766000
us-gaap Nature Of Operations
NatureOfOperations
<p id="notes_to_unaudited_consolidated_financia" style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. DESCRIPTION</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> OF BUSINESS</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has locations in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">33</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> states with concentrations in California, Texas and Pennsylvania, providing a broad range of pediatric and adult healthcare services, including nursing, hospice, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.</span></p>
CY2024Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the interim unaudited consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these interim unaudited consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></p>
CY2024Q3 avah Estimated Contractual Adjustments And Price Concessions
EstimatedContractualAdjustmentsAndPriceConcessions
83600000
CY2023Q4 avah Estimated Contractual Adjustments And Price Concessions
EstimatedContractualAdjustmentsAndPriceConcessions
62600000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1310150000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
25866000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
29209000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1284284000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1285541000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the interim unaudited consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these interim unaudited consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></p>
CY2024Q3 avah Estimated Contractual Adjustments And Price Concessions
EstimatedContractualAdjustmentsAndPriceConcessions
83600000
CY2023Q4 avah Estimated Contractual Adjustments And Price Concessions
EstimatedContractualAdjustmentsAndPriceConcessions
62600000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1310150000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1314750000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
25866000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
29209000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1284284000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1285541000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1275084000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1276341000
CY2024Q3 avah Swingline Loan
SwinglineLoan
0
CY2023Q4 avah Swingline Loan
SwinglineLoan
0
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1260600000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1275084000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1276341000
CY2024Q3 avah Swingline Loan
SwinglineLoan
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18200000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.568
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.006
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.013
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 avah Recognized Tax Benefits
RecognizedTaxBenefits
1900000
avah Recognized Tax Benefits
RecognizedTaxBenefits
1900000
CY2023Q4 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
2000000
CY2023Q4 avah Malpractice Insurance Aggregate Buffer Retention
MalpracticeInsuranceAggregateBufferRetention
1000000
CY2023Q4 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
4500000
CY2024Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
106700000
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
91800000
CY2023Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
7900000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509023000
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
349324000
CY2024Q3 us-gaap Gross Profit
GrossProfit
159699000
CY2024Q3 avah Gross Margin Percentage
GrossMarginPercentage
0.314
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
478010000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
330746000
CY2023Q3 us-gaap Gross Profit
GrossProfit
147264000
CY2023Q3 avah Gross Margin Percentage
GrossMarginPercentage
0.308
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1504634000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1040814000
CY2024Q3 us-gaap Derivative Assets
DerivativeAssets
26608000
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
53477000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18200000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1400000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.568
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.835
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.006
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.013
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 avah Recognized Tax Benefits
RecognizedTaxBenefits
1900000
avah Recognized Tax Benefits
RecognizedTaxBenefits
1900000
CY2023Q4 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
2000000
CY2023Q4 avah Malpractice Insurance Aggregate Buffer Retention
MalpracticeInsuranceAggregateBufferRetention
1000000
CY2023Q4 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
4500000
CY2024Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
106700000
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
91800000
CY2023Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
7900000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509023000
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
349324000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
478010000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
330746000
CY2023Q3 us-gaap Gross Profit
GrossProfit
147264000
CY2023Q3 avah Gross Margin Percentage
GrossMarginPercentage
0.308
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1504634000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1040814000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1416368000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
969384000
us-gaap Gross Profit
GrossProfit
446984000
avah Gross Margin Percentage
GrossMarginPercentage
0.316
CY2024Q3 us-gaap Gross Profit
GrossProfit
159699000
CY2023Q3 us-gaap Gross Profit
GrossProfit
147264000
us-gaap Gross Profit
GrossProfit
463820000
us-gaap Gross Profit
GrossProfit
446984000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88184000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91004000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
264070000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
273967000
CY2024Q3 avah Corporate Expenses
CorporateExpenses
31894000
CY2023Q3 avah Corporate Expenses
CorporateExpenses
27446000
avah Corporate Expenses
CorporateExpenses
91981000
avah Corporate Expenses
CorporateExpenses
84735000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2587000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2962000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8332000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
428000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
466000
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2860000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3360000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5271000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6593000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34024000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76352000
us-gaap Operating Income Loss
OperatingIncomeLoss
94016000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21221000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
us-gaap Investment Income Interest
InvestmentIncomeInterest
297000
us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
CY2024Q3 us-gaap Interest Expense
InterestExpense
39245000
us-gaap Gross Profit
GrossProfit
463820000
avah Gross Margin Percentage
GrossMarginPercentage
0.308
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1416368000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
969384000
us-gaap Gross Profit
GrossProfit
446984000
avah Gross Margin Percentage
GrossMarginPercentage
0.316
CY2024Q3 us-gaap Gross Profit
GrossProfit
159699000
CY2023Q3 us-gaap Gross Profit
GrossProfit
147264000
us-gaap Gross Profit
GrossProfit
463820000
us-gaap Gross Profit
GrossProfit
446984000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88184000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91004000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
264070000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
273967000
CY2024Q3 avah Corporate Expenses
CorporateExpenses
31894000
CY2023Q3 avah Corporate Expenses
CorporateExpenses
27446000
avah Corporate Expenses
CorporateExpenses
91981000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8332000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
428000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
150000
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2860000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3360000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5271000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6593000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34024000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76352000
us-gaap Operating Income Loss
OperatingIncomeLoss
94016000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21221000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
CY2024Q3 us-gaap Interest Expense
InterestExpense
39245000
CY2023Q3 us-gaap Interest Expense
InterestExpense
39599000
us-gaap Interest Expense
InterestExpense
118505000
us-gaap Interest Expense
InterestExpense
113542000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22211000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14143000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2329000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27124000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27332000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101758000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21863000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107401000
CY2023Q3 us-gaap Interest Expense
InterestExpense
39599000
us-gaap Interest Expense
InterestExpense
118505000
us-gaap Interest Expense
InterestExpense
113542000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22211000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14143000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2329000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27124000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27332000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101758000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21863000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-42843000
us-gaap Net Income Loss
NetIncomeLoss
-40109000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193361000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
193361000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189139000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189139000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
192734000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192734000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189632000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189632000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-42843000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
us-gaap Net Income Loss
NetIncomeLoss
-40109000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193361000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
193361000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189139000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189139000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
192734000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192734000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 avah Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 avah Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 avah Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-122748-index-headers.html Edgar Link pending
0000950170-24-122748-index.html Edgar Link pending
0000950170-24-122748.txt Edgar Link pending
0000950170-24-122748-xbrl.zip Edgar Link pending
avah-20240928.htm Edgar Link pending
avah-20240928.xsd Edgar Link pending
avah-ex31_1.htm Edgar Link pending
avah-ex31_2.htm Edgar Link pending
avah-ex31_3.htm Edgar Link pending
avah-ex32_1.htm Edgar Link pending
avah-ex32_2.htm Edgar Link pending
avah-ex32_3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img24676000_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
avah-20240928_htm.xml Edgar Link completed